Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-03
1999-10-26
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514404, 514255, 514307, 5462761, 546144, 544405, 5483687, C07D40104, A61K 3144
Patent
active
059729724
ABSTRACT:
A class of novel pyrazoles is disclosed together with the use of such compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
REFERENCES:
Chemical Abstracts, vol. 113: 24133 (1990), p. 682.
Chemical Abstracts, vol. 110: 104810 (1989), p. 650.
Chemical Abstracts, vol. 107: 187225 (1987).
Chemical Abstracts, vol. 107: 49477 (1987), p. 646.
Chemical Abstracts, vol. 64: 19628f (1966).
Chemical Abstracts, vol. 64: 19628e (1966).
Chemical Abstracts, vol. 63; 4012h (1965).
Chemical Abstracts, vol. 63: 4012g (1965).
Chemical Abstracts, vol. 60: 15879 (d).
Veldstra, et al., Recl. Trav. Chim. Paep Bas, 61 (1942), pp. 627-637.
Doman Peter J.
Hite Gary A.
Mihelich Edward D.
Suarez Tulio
Willetts Stuart E.
Eli Lilly and Company
Fan Jane
Palmberg Arleen
LandOfFree
Pyrazoles as human non-pancreatic secretory phospholipase A.sub. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazoles as human non-pancreatic secretory phospholipase A.sub., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazoles as human non-pancreatic secretory phospholipase A.sub. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-765026